PC
ALXO icon

Pier Capital’s ALX Oncology ALXO Stock Holding History

Pier Capital’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-271,848
Closed -$3.06M – 109
2022
Q4 		$3.06M Sell
271,848
-769
-0.3% -$8.64K 0.5% 88
2022
Q3 		$2.61M Sell
272,617
-125,128
-31% -$1.46M 0.45% 87
2022
Q2 		$3.22M Buy
397,745
+3,302
+0.8% +$36K 0.55% 80
2022
Q1 		$6.67M Buy
394,443
+93,240
+31% +$1.59M 0.85% 70
2021
Q4 		$6.47M Buy
301,203
+225,841
+300% +$9.74M 0.68% 78
2021
Q3 		$5.57M Buy
+75,362
New +$5.02M 0.58% 90

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Pier Capital's ALXO Position: Q1 2023 in Review

Pier Capital sold out of ALX Oncology (ALXO) in Q1 2023, closing a stake of 271,848 shares — an estimated $3.06M sold.

Pier Capital first reported a position in ALXO in Q3 2021 and held it in 6 quarters. The position peaked at $6.67M in Q1 2022. 86 funds tracked by Wall St. Rank hold ALXO as of Q1 2023.

  • Pier Capital reported no remaining ALX Oncology position as of Q1 2023 after selling out during the quarter.
  • Pier Capital sold 271,848 ALX Oncology shares in Q1 2023, an estimated $3.06M.
  • Pier Capital first reported a position in ALX Oncology in Q3 2021 and held it in 6 quarters.
  • Pier Capital's ALX Oncology position peaked at $6.67M in Q1 2022.
  • 86 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2023.

Based on Pier Capital's 13F filing for Q1 2023, filed 10 May 2023.